BRCA-P

Prevention

BRCA-P is a world-first trial that aims to prevent breast cancer in women with a BRCA1 gene mutation.

Breast MRI Evaluation

Early Breast Cancer

The Breast MRI Study aims to find out the best way to use breast Magnetic Resonance Imaging (MRI) and if it will improve treatment options and patient outcomes, in women recently diagnosed with…

CAPTURE

Metastatic

The CAPTURE clinical trial aims to identify women and men with hormone-receptor positive metastatic breast cancer, who may benefit from a novel combination of drugs that may improve progression free…

DECRESCENDO

Early Breast Cancer

The aim of DECRESCENDO is the find out if extra chemotherapy drugs (anthracyclines and cyclophosphamide) and their side effects can be avoided for people who are treated with combination…

DIAmOND

Metastatic

The DIAmOND clinical trial will investigate if the addition of two immunotherapy drugs to Herceptin (Trastuzumab) will improve treatments and outcomes for women and men who have HER2-positive…

EXPERT

Early Breast Cancer

EXPERT aims to improve personalised use of radiation therapy in early breast cancer patients by using a genomic test to identify women who can safely avoid this treatment after surgery and the…

FINER

Metastatic

The FINER clinical trial aims to find out if cancer will remain under control for longer in patients with advanced ER-positive and HER2-negative breast cancer.

BCT Summary of Trials and Projects

A reference table summarising BCT’s current open trials and funded Discretionary Funding projects.

The trial categories, populations, and phases can be filtered to allow researchers to refine areas of interest, identifying potential ideas for future BCT trials.

LEARN MORE ABOUT CLINICAL TRIALS

WHY I SUPPORT BREAST CANCER TRIALS